These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 4250373)
21. [Vitamin PP therapy in leprosy; sulfone intolerance and leprotic reactions]. FLOCH H; HORTH R Bull Soc Pathol Exot Filiales; 1952; 45(2):161-6. PubMed ID: 14954349 [No Abstract] [Full Text] [Related]
22. Thalidomide in leprosy therapy. Mohr W Int J Lepr Other Mycobact Dis; 1971; 39(2):598-9. PubMed ID: 4948096 [No Abstract] [Full Text] [Related]
23. Management of neuritis in leprosy. Pfaltzgraff RE Trop Doct; 1973 Jul; 3(3):138-9. PubMed ID: 4715065 [No Abstract] [Full Text] [Related]
24. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy. Hastings RC; Trautman JR; Mansfield RE Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403 [No Abstract] [Full Text] [Related]
25. [Therapeutic experience on the effect of thalidomidomide on lepra reaction]. Sheskin J Hautarzt; 1975 Jan; 26(1):1-5. PubMed ID: 1090562 [No Abstract] [Full Text] [Related]
26. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
27. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients. Hogerzeil LM Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817 [No Abstract] [Full Text] [Related]
30. The treatment of erythema nodosum leprosum with B.663. A controlled study. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017 [No Abstract] [Full Text] [Related]
31. Leprosy and Australia. Boughton CR Med J Aust; 1972 Oct; 2(15):837-42. PubMed ID: 4644391 [No Abstract] [Full Text] [Related]
32. Clinical evaluation studies in lepromatous leprosy second series: isoniazid and diasone (Diamidin) isoniazid and dihydrostreptomycin also a pilot study with streptohydrazid. DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV Int J Lepr; 1957; 25(3):173-92. PubMed ID: 13524990 [No Abstract] [Full Text] [Related]
33. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up. Magora A; Sheskin J; Sagher F; Gonen B Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246 [No Abstract] [Full Text] [Related]
34. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones. Bechelli LM; Dominguez VM Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809 [No Abstract] [Full Text] [Related]
35. Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10-(p-chlorphenyl-2,10-dihydro-2-(isopropylimino)-phenazine (G 30'320, B. 663). Vischer WA Arzneimittelforschung; 1970 May; 20(5):714-23. PubMed ID: 4988610 [No Abstract] [Full Text] [Related]
36. [Chemotherapy of leprosy--effect of the anti-leprotic agent on the growth of acid-fast bacilli in cutaneous and mucous tissue]. Hirano E Iryo; 1972 Mar; 26(3):243-53. PubMed ID: 4554827 [No Abstract] [Full Text] [Related]
37. Advances in leprosy control in the last 100 years. Bechelli LM Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732 [No Abstract] [Full Text] [Related]
38. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases]. Privat Y; Faye I; Bellossi A Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252 [No Abstract] [Full Text] [Related]